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Abstract
Background—Reporting of quality indicators (QIs) in Veterans Health Administration Medical
Centers is complicated by estimation error due to small numbers of eligible patients per facility.
We applied multilevel modeling and empirical Bayes (EB) estimation in addressing this issue in
performance reporting of stroke care quality in the Medical Centers.
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Methods and Results—We studied a retrospective cohort of 3812 veterans admitted to 106
Medical Centers with ischemic stroke during fiscal year 2007. The median number of study
patients per facility was 34 (range: 12-105). Inpatient stroke care quality was measured with
thirteen evidence-based QIs. Eligible patients could either pass or fail each indicator. Multilevel
modeling of a patient’s pass/fail on individual QIs was used to produce facility-level EB estimated
QI pass rates and confidence intervals. The EB estimation reduced inter-facility variation in QI
rates. Small facilities and those with exceptionally high or low rates were most affected. We
recommended 8 of the 13 QIs for performance reporting: dysphagia screening, NIH Stroke Scale
documentation, early ambulation, fall risk assessment, pressure ulcer risk assessment, Functional
Independence Measure documentation, lipid management, and deep vein thrombosis prophylaxis.
These QIs displayed sufficient variation across facilities, had room for improvement, and
identified sites with performance that was significantly above or below the population average.
The remaining 5 QIs were not recommended because of too few eligible patients or high pass rates
with little variation.
Conclusions—Considerations of statistical uncertainty should inform the choice of QIs and
their application to performance reporting.
Keywords
acute stroke; performance measurement; quality indicators; stroke management; statistics
Quality assessment systems are being adopted widely in the health care industry for
performance incentives and public reporting. Controversy surrounds the choice of the
quality measures, risk adjustment methods, and quality thresholds or standards1-4. Another
issue receiving increased attention is the problem of estimation error or the statistical
uncertainty associated with quality measures based on small numbers of observations per
facility 5-10. Estimation error, if unrecognized or inadequately dealt with, can undermine the
performance assessment and make it difficult to draw fair comparisons among
organizations.
The Veterans Health Administration (VHA) has a long-standing tradition of performance
measurement across a variety of disease conditions and often out-performs the private
sector 11-13. We recently conducted a study of the quality of inpatient ischemic stroke care in
Veterans Administration Medical Centers 14. A goal of the study was to recommend stroke
quality indicators (QIs) for potential adoption by the VHA quality reporting system. Dealing
with uncertainty in facility QI rates was a major concern in making recommendations. The
QI rates represented the number of eligible patients “passing” a recommended care process.
Although the QI rates were informative at the population level, we found it difficult to draw
conclusions about facility-level performance because of the low volume of stroke cases at
many hospitals. The median number of annual stroke cases per facility was 34 among the
129 hospitals in the study. Exclusions of ineligible patients further reduced the denominators
for several QIs. The smaller the denominator for a facility’s QI rate, i.e., number patients
eligible for a QI, the greater the imprecision or uncertainty of the QI estimate and the more
likely a hospital being evaluated would appear as an outlier, with either exceptionally high
or low quality, through chance alone.
In the present study we selected an approach, multilevel modeling, that could address
estimation error and identify candidate QIs for facility performance assessment in the VHA.
Our study objectives were to: (1) construct facility-level estimated inpatient stroke QI rates
based on multilevel models and empirical Bayes (EB) estimation methods, (2) compare the
EB-estimated with observed QI rates to determine effects of EB estimation on facility QI
rates and outlier status, (3) evaluate how well each QI discriminated between facilities, and
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(4) draw conclusions about which stroke QIs would be most useful for performance
reporting across hospitals.
Methods
Patients and Setting
The VHA Office of Quality Performance and the VA Stroke Quality Enhancement Research
Initiative (QUERI) collaborated to conduct the first VHA study of national in-patient
ischemic stroke care quality using 14 process indicators based largely on the Joint
Commission Standardized Stroke Measure Set 15. The study design and primary findings
have been reported elsewhere 14 (see: The Quality of VA Inpatient Ischemic Stroke Care,
Supplemental Materials).
The total study sample consisted of 3,931 veterans admitted to 129 hospitals in fiscal year
2007 with a primary discharge diagnosis of ischemic stroke based on ICD-9 codes from
administrative data 16. All patients admitted with stroke to lower volume centers (≤55
patients in fiscal year 2007) and a random 80% sample of patients admitted with stroke at
higher volume centers (>55 patients in fiscal year 2007) were sampled. The cut-off of 55
patients was chosen in order to optimize the number of sampled patients from smaller
volume facilities while staying within budget constraints. Patients were excluded from the
sample if they were admitted for elective carotid endarterectomy, admitted only for post-
stroke rehabilitation, were already admitted for a non-stroke condition when the ischemic
stroke event occurred, or were admitted to a hospital that did not use the VHA electronic
medical record system. For purposes of our current analysis we excluded from the total
sample 23 hospitals with fewer than 12 patients (fewer than 1 stroke admission per month on
average) because results for these very low volume facilities would be highly unreliable.
The cut-off of 12 patients was selected arbitrarily. We set a low cut-off with the intention of
including as many facilities as possible. The resulting analysis sample was 3,812 patients
from 106 hospitals. The median number of patients per facility was 34 with a range of 12 to
105.
Data were collected through retrospective chart review of medical records using remote
electronic medical record data only (not paper medical records), performed by abstractors
from the West Virginia Medical Institute (WVMI) who were specially trained for this study.
Among the 307 data elements, 90% had an inter-observer agreement ≥70%. The
institutional review board approved this study.
Quality Indicators
Thirteen of the 14 study QIs were included in this analysis: dysphagia screening before oral
intake, documentation of stroke severity using the NIH Stroke Scale (NIHSS), thrombolysis
(tPA) given, antithrombotic therapy by hospital day two and at discharge, deep vein
thrombosis (DVT) prophylaxis, early ambulation, fall risk assessment, pressure ulcer risk
assessment, and rehabilitation needs assessment based on documentation of the Functional
Independence Measure (FIM), atrial fibrillation management at discharge, lipid management
at discharge, and smoking cessation counseling 14 (see: The Quality of VA Inpatient
Ischemic Stroke Care, Supplemental Materials, for detailed definitions). The 14th QI that
was included in the original study pertained to stroke education but this QI was excluded
from the current analysis because of unreliable documentation.
Patient-level QIs were measured as a binary variable for eligible patients: pass or fail. A
facility’s QI rate was the number of passes divided by the number of patients who were
eligible for that QI. Patients were excluded from the calculation for an indicator if they had
characteristics or conditions making them ineligible 14 (see: The Quality of VA Inpatient
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Ischemic Stroke Care, Supplemental Materials). The analysis did not include additional
patient risk-adjusters because appropriateness of the care process had already been dealt
with in the QI definition through patient exclusion criteria.
Multilevel Modeling and Empirical Bayes Estimates
We based our analysis on a multilevel modeling approach, which takes into account the
nested and correlated structure of quality assessment data (e.g., patients nested within
hospitals). It is better suited to deal with estimation error and other estimation problems
compared with conventional regression methods that do not deal adequately with the
hierarchal nature of these data 4, 17-20. Multilevel models generally provide more precise and
reliable estimates and more valid conclusions about performance, particularly when
providers differ widely in the volume of patient populations 21-26.
The multilevel models produce empirical Bayes (EB) estimates of facility QI rates. The EB-
estimated QI rates were developed in stages with the HLM 6.0 statistical package (Scientific
Software International, Chicago IL). First, we constructed hierarchical general linear
(HGLM) models for each of the 13 quality indicators. The binary patient-level QI outcome
(pass or fail) was modeled with facility treated as a random effect 27. The models assumed a
logit link function and Bernoulli distribution and we used EM Laplace estimation 28. These
were null or unconditional models containing a facility error term but no patient or facility
variables. Only patients who were eligible for a QI were included in the model for that QI.
From the patient-level models we output facility-level empirical Bayes (EB) residuals to
represent the variance in a facility’s QI rate 28. The EB residuals differ from ordinary least
squares residuals in that they take into account differences between facilities in the
reliability of their estimates. As noted earlier, facilities with small numbers of stroke patients
are likely to have less reliable estimates compared to facilities with a higher volume of
stroke admissions. The EB estimator, sometimes referred to as a “shrinkage estimator,”
produces more precise and reliable and usually more conservative estimates because rates
for small outlier facilities are pulled to the population mean 28-30. The HLM software
produces EB residuals for each QI in each facility. For ease of interpretation we calculated
standardized QI rates by adding the EB residuals to the grand mean QI rate for the facility
population. Facilities with a positive residual for a QI had a standardized rate above the
mean, while negative residuals resulted in standardized rates below the population mean.
For example, the mean pass rate for the fall risk assessment QI was .78. If a facility had an
EB residual of .05 then its standardized rate would be .83; if its EB residual were -.05 then
its standardized rate would be .73. By standardizing the EB QI rates in this manner, we are
able to make direct comparisons to the observed QI rates. The HLM software also outputs a
standard error for each residual that was used to construct 90% confidence intervals around
the EB estimated rate.
Quality Thresholds
The study had no predetermined standards or thresholds for stroke care quality performance.
We sought to test three approaches for threshold setting that have been applied generally in
health care quality assessment. One approach relied on tests of statistical significance where
EB QI estimates and confidence intervals were compared to a quality threshold. We chose
the population mean as one threshold. Facilities with QI confidence intervals entirely above
the population mean would have significantly better than average quality; facilities with QI
confidence intervals entirely below the mean would have significantly poorer quality; and
facilities overlapping the mean would be uncertain (i.e., neither above nor below average).
The population average threshold becomes problematic when performance is generally poor
in a QI area (e.g., dysphagia screening or NIHSS documentation) or quite good overall (e.g.,
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antithrombotics by day 2). Therefore, we selected an alternative threshold based on an
absolute standard of an 85% pass rate that could be applied across all of the QIs. The 85%
pass rate is the benchmark used by the American Heart Association Get with the Guidelines
Stroke Recognition Program in recognizing achievements in stroke care quality 31. Facilities
would be designated as good, poor, or uncertain if their QI confidence intervals fell above,
below or crossed over an 85% threshold. Finally, a third approach relied on outlier status: a
facility ranked below the 10th percentile would be a low performer and above the 90th
percentile a high performer. We chose the 90% CI rather than a 95% CI because we wanted
greater sensitivity in identifying facilities that might be providing good or poor care, i.e., CIs
above or below our thresholds.
Results
Facilities varied considerably in the number of stroke patients admitted and patients eligible
for each QI (Table 1). No facility had 12 or more patients for the tPA administration or atrial
fibrillation management QIs. Therefore, we did not report results for these QIs. Only 31
facilities had ≥12 patients eligible for the DVT prophylaxis QI and 41 facilities had ≥12
patients eligible for the smoking cessation counseling QI. At least 90 facilities had ≥12
eligible patients for the remaining QIs; the median number of eligible patients per facility
ranged from 19-35. Even among the highest volume facilities (90th percentile) the number of
eligible patients per QI ranged from only 47-58.
Facility Quality Indicator (QI) Rates
Table 2 shows the observed and estimated QI rates for the 11 QIs that had analyzable
results. Facilities performed very well on several QIs. The mean observed pass rates were
above 85% on the QIs for antithrombotics by day 2 and at discharge, early ambulation,
pressure ulcer risk assessment, and smoking cessation counseling. Performance on other QIs
was generally poor: the dysphagia screening prior to oral intake process had an observed
mean pass rate of only 0.173 and the NIHSS stroke scale documentation rate was only
0.250. The observed mean pass rates for the other QIs ranged from 0.749 (DVT prophylaxis)
to 0.815 (lipid management at discharge). The facilities displayed modest variation in
observed QI rates with the NIH Stroke Scale and fall risk assessment having the greatest
variation in rates (SD = 0.380 and SD = 0.335, respectively; see Table 2).
EB-Estimated Facility Performance
The EB-estimated QI rates displayed a pattern similar to the observed rates. Means for the
facility QI rates changed very little between observed and EB estimated (see Table 2). The
main effect of EB estimation was to reduce (shrink) the variation in QI rates; standard
deviations declined for all of the EB QIs compared to the observed QIs. Similarly, the range
in rates between facilities at the 10th and 90th percentiles narrowed. Facilities farther away
from the mean were likely to experience greater shrinkage.
Table 3 shows the impact of EB estimation on the facility QI rates and outlier status. The
table displays the average absolute difference in observed and EB QI rates (absolute value of
the facility’s EB rate minus its observed rate). The mean absolute differences ranged from a
low of 0.004 (SD=0.004, interquartile range=.002-.005) for NIHSS documentation to a high
of 0.053 (SD=0.048, interquartile range=.021-.088) for DVT prophylaxis.
We would expect EB estimation to have its greatest impact at the tails of the distribution
where the greatest EB shrinkage is likely to occur. Table 3 summarizes facility movement
into or out of outlier status (i.e., above the 90th percentile or below the 10th percentile).
Some QIs having the highest observed rates (i.e., antithrombotics by day 2, antithrombotics
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at discharge, fall risk assessment, and early ambulation) had several facilities with observed
QIs rates of 1.000. This created tied rankings for top outlier status. The EB estimation
removed the ties through QI shrinkage away from 1.000. As a consequence, the greatest
movement out of top outlier status occurred for QIs having the most tied facilities.
Nonetheless facilities displayed considerable movement in or out of outlier status for all of
the QIs. For example, 5 facilities became bottom outliers while 5 facilities moved out of the
bottom outlier status on the FIM administration QI; and, 2 facilities became top outliers and
13 facilities moved out of top outlier status on the early ambulation QI.
Confidence Intervals
Given the small denominators for many of the facility QIs, we would expect considerable
uncertainty in the estimates even among EB rates. The confidence intervals around these
estimates can be a valuable tool in evaluating performance while taking into account the
uncertainty of the QI rate. Figures 1 and 2 illustrate the application of confidence intervals to
EB QI rates for lipid management that has generally high pass rates and dysphagia screening
that has generally low pass rates. The width of the confidence intervals (i.e., precision of the
QI estimates) is mainly a function of the facility QI denominators. Facilities having more
patients eligible for a QI will have more precise and reliable estimates. Although we chose a
90% CI because of its greater sensitivity in detecting good or poor performance, a 95% CI
could be used in a QI reporting system where specificity, i.e., minimizing false positives,
was of greater concern.
Quality Thresholds
We relied on EB rates and confidence intervals in deciding which facilities were good or
poor performers on the 11 analyzable QIs (Table 4). Our first approach, comparing the
confidence intervals for the facilities’ EB QI rates to the population mean, discriminated
relatively well for 8 of the 11 QIs. However, this method discriminated poorly for three QIs
with the highest pass rates (i.e., antithrombotics by day 2, antithrombotics at discharge, and
Smoking cessation counseling) where no more than 5% of facilities were significantly above
or below the population average.
Facilities also varied significantly in their performance compared to the 85% pass rate
standard on most of the QIs. For example, 41% of facilities were significantly above and
15% significantly below the standard on the early ambulation QI, 43% were above and 22%
below on fall risk assessment, and 60% above and 8% below on pressure ulcer assessment.
Only 12% of facilities were significantly above while 80% were significantly below the
standard for NIH Stroke Scale administration. The standard discriminated very little
between facilities on the other QIs. All facilities fell significantly below the 85% pass rate
for the dysphagia screening, none was significantly above the standard for DVT
prophylaxis, and none was significantly below the standard for smoking cessation
counseling. Almost all facilities were above the 85% standard for the antithrombotic QIs at
day 2 and at discharge.
Discussion
Our study demonstrates an approach for dealing with the problem of estimation error, a
serious issue in assessing the quality of inpatient ischemic stroke care in the VHA and other
health care settings. The low volume of stroke admissions in many VHA facilities leads to
uncertainty about their true QI rates. We approached this problem by first setting a threshold
of at least 12 patients (one patient per month) in the QI denominator before a facility’s QI
rate would be reported. Secondly, we developed multilevel models for estimating patient
pass rates in each facility for the 13 QIs. The models generated empirical Bayes (EB)
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estimates and 90% confidence intervals around these estimates. The EB estimation narrowed
the between-facility variance in QI rates. The QI rates in smaller facilities with extreme
values were pulled toward the population average QI rate, reducing the likelihood that these
facilities would be labeled QI outliers. By constructing 90% confidence intervals around the
EB QI rates we were able to discriminate statistically between good and poor performing
facilities using both the population mean and an 85% pass rate as quality thresholds.
Advantages over Conventional Methods of QI Reporting
The EB estimation offers advantages over conventional methods of calculating QI rates. One
method of QI reporting is to simply ignore estimation error and report observed QI rates
leaving the user with little guidance as to the uncertainty in the estimates. Another method is
to report observed rates but excludes small volume facilities from QI calculations if they do
not attain a minimum number of patients in the QI denominator. This method is problematic
because it leaves unreported the QI rates for small volume facilities and because it fails to
take into account differences in estimation error among facilities above the threshold 30. A
third method is to report observed rates with conventional confidence intervals. The
confidence intervals convey the amount of uncertainty associated with the rates in small
facilities, but having such broad confidence intervals makes it difficult to draw inference
about care quality.
The EB estimation approach is an improvement over these methods. It is grounded in
Bayesian statistical theory, uses information about QI rates in the patient population and
variation in rates between facilities to inform the estimation process, and produces estimates
that are more precise and reliable and with narrower confidence intervals than conventional
methods27, 29. One concern frequently raised about EB estimates is the conservative bias
inherent in shrinkage. Low volume, outlier facilities having poor QI scores may be “let off
the hook” as their QI rates shrink toward the population mean. We should point out that
shrinkage is bidirectional: small volume facilities with exceptionally good and poor scores
will both experience shrinkage. We feel that a conservative approach is warranted from a
policy perspective. We want to avoid penalizing low volume facilities by falsely labeling
then as having exceptionally poor care. This approach runs the risk of some facilities with
poor quality being undetected or good quality unrewarded. We recognize that outlier status
based on rankings can be highly variable and uncertain19, 20 and, thus, we would caution
against this approach, recommending instead the application of confidence intervals in
relation to benchmarks (85% pass rate).
Recommended QIs for Performance Reporting of VHA Stroke Quality
Seven of the 13 stroke quality indicators in our analysis would be good candidates for public
reporting: dysphagia screening, NIH Stroke Scale documentation, early ambulation, fall risk
assessment, pressure ulcer assessment, FIM documentation, and lipid management. These
QIs are recommended for use for the following reasons. First, they can be calculated and
reported for the majority of hospitals (i.e., at least 95 facilities had 12 or more patients in the
denominators for these QIs). Second, they had reasonably large inter-facility variation in QI
pass rates even after EB estimation. As an indication of variation, their standard deviations
ranged from 0.071 (lipid management) to 0.375 (NIHSS administered). Third, their mean
EB pass rates were neither exceptionally low nor high; they ranged from 0.172 to 0.920.
Finally, these QIs discriminated reasonably well between facilities according to our quality
threshold approaches. Among the seven QIs, no fewer than 8% of facilities had EB pass
rates significantly below their population average, and at least 10% of facilities were
significantly above the their population average. The proportion of facilities significantly
below an 85% pass rate standard was no less than 8%, and the proportion above 85% was no
greater than 60%.
Arling et al. Page 7
Circ Cardiovasc Qual Outcomes. Author manuscript; available in PMC 2013 January 1.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Some of the QIs in our study differ from measures in other national reporting systems.
Dysphagia screening was recently dropped from the set of stroke measures proposed by
National Quality Forum (NQF) despite evidence linking dysphagia screening with
improvements in important clinical outcomes 14. Also, fall risk assessment, pressure ulcer
assessment, FIM documentation are not NQF recommended measures for stroke; however,
these processes are embedded strongly in the VHA culture and have important implications
for clinical outcomes.
The DVT prophylaxis QI is not among the seven recommended measures because it had
only 31 facilities with 12 or more eligible patients. In other respects this QI meets our
criteria. The DVT prophylaxis QI has a strong evidence base, an important consideration in
QI reporting 32. The 31 facilities included in the QI denominator had a reasonable
population average QI rate (0.751); 13% of facilities were significantly below and 12%
significantly above average on this QI; and 36% were significantly below the 85% pass rate
standard, leaving room for improvement. The DVT prophylaxis QI could be informative for
facilities with sufficient numbers of eligible patients.
The remaining 5 measures, while not recommended for facility performance reporting, are
still clinically important and worthy of measurement and tracking. The tPA administration
for the treatment of acute stroke and management of atrial fibrillation processes have a
strong evidence base 32. Although these two QIs had too few patients per facility for reliable
performance reporting, these clinically meaningful care processes could be treated as
sentinel events with a focus on individual occurrences of failure. The remaining QIs –
antithrombotic by day 2, antithrombotic by discharge, and smoking cessation counseling
have very high average pass rates (>0.950). These measures should be tracked because of
their clinical importance, yet they should not be part of a performance reporting system
because they do not offer meaningful comparisons between facilities.
Because of their greater precision the EB rates should be a more reliable basis for
performance assessment not only in a single time period but also in drawing comparisons
over multiple time periods. Stroke admission rates have been stable over the last 5 years. If
the recommended QIs are to be applied to performance assessment and publicly reported,
then data should be collected in a consistent manner from year to year. Key data elements
should be incorporated into the VHA administrative and clinical systems. We are exploring
the feasibility of measuring the QIs from administrative and clinical systems on an ongoing
basis without abstracting. Our study suggests that 12 months of data would be required for
QI reporting. Data could be reported every calendar quarter using a 12-month rolling
average with data updated each quarter.
We tested the sensitivity of the findings to our choice of a 12-patient minimum for facility
QI reporting. Increasing the minimum number of patients required for calculating a facility’s
QI rate yielded more reliable QI estimates and reduced the difference between observed and
EB estimated QI rates. Yet, increased reliability came at a price. For example, a 25- patient
minimum reduced the number of VAMCs per QI from an average of 88 to 55, with a
maximum of 70 facilities (pressure sore risk assessment) and minimum of 6 facilities (DVT
prophylaxis) having reportable QI rates.
Limitations
Our study has limitations. First, we concentrated on the issue of estimation error. Other
issues such as the clinical significance, measurement validity and reliability, eligibility
criteria, and potential for quality improvement may have an equal or even greater impact on
the choice of QIs for the inpatient stroke quality reporting system 10, 33. Second, the study
was conducted within the VHA, which has unique delivery system characteristics and
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patient population characteristics that may make findings difficult to generalize to other
settings 11. Third, statistical estimation is complex and may be difficult for providers or
consumers to understand or difficult for hospital systems to calculate. The EB QI rates with
confidence intervals may be most appropriate for system-level applications where facilities
must be compared against their peers in quality report cards or pay-for-performance
programs. The EB rates should be accompanied by observed rates, particularly for quality
improvement purposes where providers may want to investigate individual passes and
failures. Finally, we did not attempt to develop a composite QI where scores on individual
QIs could be combined into a single measure. Although composite measures tend to be more
reliable than individual measures, they may obscure differences in performance between
care domains and some individual measures may dominate others.34
Conclusion
Despite these limitations the study demonstrates an approach for dealing with statistical
uncertainty using multilevel modeling and empirical Bayes estimation; it resulted in QI
estimates and confidence intervals that discriminate well between good and poor performing
facilities; and it identified reportable stroke care quality indicators that met our criteria for
performance reporting.
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What is known?
• Quality of inpatient stroke care is a serious concern that can affect patient
outcomes such as functional status and mortality
• Quality indicators (QIs) can provide useful information for public reporting,
performance incentives, and quality improvement, although prior to this study
the Veterans Health Administration did not have QIs for the quality of inpatient
stroke care.
• Drawing inference about the “true” quality of stroke care for a specific hospital
and making valid comparisons between hospitals is complicated by estimation
error, particularly when hospitals have a low volume of stroke patients or they
vary widely the volume of their patients.
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What this article adds?
• We present a method for dealing with QI estimation error that relies on a
multilevel framework, i.e., patients nested within hospitals, and an empirical
Bayes estimator.
• We demonstrate the practical application of this method in estimating and
reporting on the quality of stroke care using 14 care process QIs in an annual
cohort of 3812 inpatient ischemic stroke patients in 106 Veterans Health
Administration medical centers.
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Figure 1.
The vertical axis is the EB estimated QI rate. Case numbers on the horizontal axis are
randomly assigned facility ID numbers. Not all cases are labeled due to space constraints.
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Figure 2.
The vertical axis is the EB estimated QI rate. Case numbers on the horizontal axis are
randomly assigned facility ID numbers. Not all cases are labeled due to space constraints.
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